{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:05:56Z","timestamp":1783065956571,"version":"3.54.6"},"reference-count":28,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej15-0392","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T22:07:00Z","timestamp":1447711620000},"page":"111-118","source":"Crossref","is-referenced-by-count":39,"title":["Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients"],"prefix":"10.1507","volume":"63","author":[{"given":"Feyza","family":"Yener Ozturk","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvinaz","family":"Erol","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Masum","family":"Canat","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savas","family":"Karatas","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Kuzu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezin","family":"Dogan Cakir","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuksel","family":"Altuntas","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maruani G, Hertig A, Paillard M, Houillier P (2003) Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. <i>J Clin Endocrinol Metab<\/i> 88: 4641-4648.","DOI":"10.1210\/jc.2002-021404"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Silverberg SJ, Bilezikian JP (2003) &ldquo;Incipient&rdquo; primary hyperparathyroidism: a &ldquo;forme frust&rdquo; of an old disease. <i>J Clin Endocrinol Metab<\/i> 88: 5348-5352.","DOI":"10.1210\/jc.2003-031014"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bilezikian JP, Silverberg SJ (2010) Normocalcemic primary hyperparathyroidism. <i>Arq Bras Endocrinol Metabol<\/i> 54: 106-109.","DOI":"10.1590\/S0004-27302010000200004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. <i>J Clin Endocrinol Metab<\/i> 67: 1294-1298.","DOI":"10.1210\/jcem-67-6-1294"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lundgren E, Lind L, Palm&eacute;r M, Jakobsson S, Ljunghall S, et al. (2001) Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. <i>Surgery<\/i> 130: 978-985.","DOI":"10.1067\/msy.2001.118377"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Headb&auml;ck G, Od&eacute;n A (1998) Increased risk of death from primary hyperparathyroidism- an update. <i>Eur J Clin Invest<\/i> 28: 271-276.","DOI":"10.1046\/j.1365-2362.1998.00289.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Raue F (1998) Increased incidence of cardiovascular diseases in primary hyperparathyroidism- a cause for more aggressive treatment? <i>Eur J Clin Invest<\/i> 28: 277-278.","DOI":"10.1046\/j.1365-2362.1998.00290.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bergenfelz A, Bladstr&ouml;m A, Their M, Nordenstr&ouml;m E, Valdemarsson S, et al. (2007) Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study. <i>World J Surg<\/i> 31: 1393-1400.","DOI":"10.1007\/s00268-007-9091-6"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ishay A, Herer P, Luboshitzky R (2011) Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism. <i>Endocr Pract<\/i> 17: 584-590.","DOI":"10.4158\/EP10321.OR"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Garcia de la Torre N, Wass JA, Turner HE (2003) Parathyroid adenomas and cardiovascular risk. <i>Endocr Relat Cancer<\/i> 10: 309-322.","DOI":"10.1677\/erc.0.0100309"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rubin MR, Silverberg SJ (2012) Glucose intolerance and primary hyperparathyroidism: an unresolved relationship. <i>Endocrine<\/i> 42: 231-233.","DOI":"10.1007\/s12020-012-9674-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hagstr&ouml;m E, Lundgren E, Rastad J, Hellman P (2006) Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. <i>Eur J Endocrinol<\/i> 155: 33-39.","DOI":"10.1530\/eje.1.02173"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Carneiro-Pla D, Solorzano C (2012) A summary of the new phenomenon of normocalcemic hyperparathyroidism and appropriate management. <i>Curr Opin Oncol <\/i>24: 42-45.","DOI":"10.1097\/CCO.0b013e32834c2fb9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ayturk S, Gursoy A, Bascil Tutuncu N, Ertugrul DT, Guvener Demirag N (2006) Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism. <i>J Clin Endocrinol Metab<\/i> 91: 4260-4263.","DOI":"10.1210\/jc.2005-2825"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tordjman KM, Yaron M, Izkhakov E, Osher E, Shenkerman G (2010) Cardiovascular risk factors and arterial rigidity are similar in asypmtomatic normocalcemic and hypercalcemic primary hyperparathyroidism. <i>Eur J Endocrinol<\/i> 162: 925-933.","DOI":"10.1530\/EJE-09-1067"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cakir I, Unluhizarci K, Tanriverdi F, Elbuken G, Karaca Z, et al. (2012) Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism. <i>Endocrine<\/i> 42: 419-422.","DOI":"10.1007\/s12020-012-9627-x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. <i>Diabetes Care<\/i> 22: 1462-1470.","DOI":"10.2337\/diacare.22.9.1462"},{"key":"18","unstructured":"18. International Diabetes Federation (2006). The IDF worldwide definition of the metabolic syndrome. https:\/\/www.idf.org\/metabolic-syndrome."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Neunteufl T, Heher S, Prager G, Katzenschlager R, Abela C, et al. (2000) Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcemia: results of a 3-year follow-up study. <i>Clin Endocrinol (Oxf)<\/i> 53: 229-233.","DOI":"10.1046\/j.1365-2265.2000.01076.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Draznin B, Lewis D, Houlder N, Sherman N, Adamo M, et al. (1989) Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. <i>Endocrinology<\/i> 125: 2341-2349.","DOI":"10.1210\/endo-125-5-2341"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hagstr&ouml;m E, Lundgren E, Lithell H, Berglund L, Ljunghall S, et al. (2002) Normalized dyslipidemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. <i>Clin Endocrinol(Oxf)<\/i> 56: 253-260.","DOI":"10.1046\/j.0300-0664.2001.01468.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, et al. (2000) Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. <i>Metabolism<\/i> 49: 1501-1505.","DOI":"10.1053\/meta.2000.17708"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Prager R, Kovarik J, Schernthaner G, Woloszczuk W, Willvonseder R (1983) Peripheral insulin resistance in primary hyperparathyroidism. <i>Metabolism<\/i> 32: 800-805.","DOI":"10.1016\/0026-0495(83)90110-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R (1992) Insulin sevretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. <i>Clin Endocrinol(Oxf) <\/i>37: 147-155.","DOI":"10.1111\/j.1365-2265.1992.tb02299.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tassone F, Procopio M, Gianotti L, Visconti G, Pia A, et al. (2009) Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. <i>Diabet Med<\/i> 26: 968-973.","DOI":"10.1111\/j.1464-5491.2009.02804.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kumar S, Olukoga AO, Gordon C, Mawer EB, France M, et al. (1994) Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. <i>Clin Endocrinol(Oxf)<\/i> 40: 47-53.","DOI":"10.1111\/j.1365-2265.1994.tb02442.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rudman A, Pearson ER, Smith D, Srivastava R, Murphy MJ, et al. (2010) Insulin resistance before and after parathyroidectomy in patients with primary hyperparathyroidism- A pilot study. <i>Endocr Res<\/i> 35: 85-93.","DOI":"10.3109\/07435801003724503"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Maestro B, D&aacute;vila N, Carranza MC, Calle C (2003) Identification of a Vitamin D response element in the human inulin receptor gene promoter. <i>J Steroid Biochem Mol Biol<\/i> 84: 223-230.","DOI":"10.1016\/S0960-0760(03)00032-3"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/2\/63_EJ15-0392\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:45:41Z","timestamp":1498261541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/2\/63_EJ15-0392\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0392","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}